Global Bispecific Monoclonal Antibodies Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Bispecific Monoclonal Antibodies will have significant change from previous year. According to our (LP Information) latest study, the global Bispecific Monoclonal Antibodies market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Bispecific Monoclonal Antibodies market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Bispecific Monoclonal Antibodies market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bispecific Monoclonal Antibodies market, reaching US$ million by the year 2028. As for the Europe Bispecific Monoclonal Antibodies landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Bispecific Monoclonal Antibodies players cover Roche (Chugai), Amgen, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bispecific Monoclonal Antibodies market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Fragment-Based Antibodies
IgG-Based Antibodies
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Haemophilia
Other Non-Cancer Diseases
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche (Chugai)
Amgen
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bispecific Monoclonal Antibodies Market Size 2017-2028
2.1.2 Bispecific Monoclonal Antibodies Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Bispecific Monoclonal Antibodies Segment by Type
2.2.1 Fragment-Based Antibodies
2.2.2 IgG-Based Antibodies
2.3 Bispecific Monoclonal Antibodies Market Size by Type
2.3.1 Bispecific Monoclonal Antibodies Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Bispecific Monoclonal Antibodies Market Size Market Share by Type (2017-2022)
2.4 Bispecific Monoclonal Antibodies Segment by Application
2.4.1 Cancer
2.4.2 Haemophilia
2.4.3 Other Non-Cancer Diseases
2.5 Bispecific Monoclonal Antibodies Market Size by Application
2.5.1 Bispecific Monoclonal Antibodies Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Bispecific Monoclonal Antibodies Market Size Market Share by Application (2017-2022)
3 Bispecific Monoclonal Antibodies Market Size by Player
3.1 Bispecific Monoclonal Antibodies Market Size Market Share by Players
3.1.1 Global Bispecific Monoclonal Antibodies Revenue by Players (2020-2022)
3.1.2 Global Bispecific Monoclonal Antibodies Revenue Market Share by Players (2020-2022)
3.2 Global Bispecific Monoclonal Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bispecific Monoclonal Antibodies by Regions
4.1 Bispecific Monoclonal Antibodies Market Size by Regions (2017-2022)
4.2 Americas Bispecific Monoclonal Antibodies Market Size Growth (2017-2022)
4.3 APAC Bispecific Monoclonal Antibodies Market Size Growth (2017-2022)
4.4 Europe Bispecific Monoclonal Antibodies Market Size Growth (2017-2022)
4.5 Middle East & Africa Bispecific Monoclonal Antibodies Market Size Growth (2017-2022)
5 Americas
5.1 Americas Bispecific Monoclonal Antibodies Market Size by Country (2017-2022)
5.2 Americas Bispecific Monoclonal Antibodies Market Size by Type (2017-2022)
5.3 Americas Bispecific Monoclonal Antibodies Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bispecific Monoclonal Antibodies Market Size by Region (2017-2022)
6.2 APAC Bispecific Monoclonal Antibodies Market Size by Type (2017-2022)
6.3 APAC Bispecific Monoclonal Antibodies Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bispecific Monoclonal Antibodies by Country (2017-2022)
7.2 Europe Bispecific Monoclonal Antibodies Market Size by Type (2017-2022)
7.3 Europe Bispecific Monoclonal Antibodies Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bispecific Monoclonal Antibodies by Region (2017-2022)
8.2 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Type (2017-2022)
8.3 Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Bispecific Monoclonal Antibodies Market Forecast
10.1 Global Bispecific Monoclonal Antibodies Forecast by Regions (2023-2028)
10.1.1 Global Bispecific Monoclonal Antibodies Forecast by Regions (2023-2028)
10.1.2 Americas Bispecific Monoclonal Antibodies Forecast
10.1.3 APAC Bispecific Monoclonal Antibodies Forecast
10.1.4 Europe Bispecific Monoclonal Antibodies Forecast
10.1.5 Middle East & Africa Bispecific Monoclonal Antibodies Forecast
10.2 Americas Bispecific Monoclonal Antibodies Forecast by Country (2023-2028)
10.2.1 United States Bispecific Monoclonal Antibodies Market Forecast
10.2.2 Canada Bispecific Monoclonal Antibodies Market Forecast
10.2.3 Mexico Bispecific Monoclonal Antibodies Market Forecast
10.2.4 Brazil Bispecific Monoclonal Antibodies Market Forecast
10.3 APAC Bispecific Monoclonal Antibodies Forecast by Region (2023-2028)
10.3.1 China Bispecific Monoclonal Antibodies Market Forecast
10.3.2 Japan Bispecific Monoclonal Antibodies Market Forecast
10.3.3 Korea Bispecific Monoclonal Antibodies Market Forecast
10.3.4 Southeast Asia Bispecific Monoclonal Antibodies Market Forecast
10.3.5 India Bispecific Monoclonal Antibodies Market Forecast
10.3.6 Australia Bispecific Monoclonal Antibodies Market Forecast
10.4 Europe Bispecific Monoclonal Antibodies Forecast by Country (2023-2028)
10.4.1 Germany Bispecific Monoclonal Antibodies Market Forecast
10.4.2 France Bispecific Monoclonal Antibodies Market Forecast
10.4.3 UK Bispecific Monoclonal Antibodies Market Forecast
10.4.4 Italy Bispecific Monoclonal Antibodies Market Forecast
10.4.5 Russia Bispecific Monoclonal Antibodies Market Forecast
10.5 Middle East & Africa Bispecific Monoclonal Antibodies Forecast by Region (2023-2028)
10.5.1 Egypt Bispecific Monoclonal Antibodies Market Forecast
10.5.2 South Africa Bispecific Monoclonal Antibodies Market Forecast
10.5.3 Israel Bispecific Monoclonal Antibodies Market Forecast
10.5.4 Turkey Bispecific Monoclonal Antibodies Market Forecast
10.5.5 GCC Countries Bispecific Monoclonal Antibodies Market Forecast
10.6 Global Bispecific Monoclonal Antibodies Forecast by Type (2023-2028)
10.7 Global Bispecific Monoclonal Antibodies Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche (Chugai)
11.1.1 Roche (Chugai) Company Information
11.1.2 Roche (Chugai) Bispecific Monoclonal Antibodies Product Offered
11.1.3 Roche (Chugai) Bispecific Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche (Chugai) Main Business Overview
11.1.5 Roche (Chugai) Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Bispecific Monoclonal Antibodies Product Offered
11.2.3 Amgen Bispecific Monoclonal Antibodies Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Bispecific Monoclonal Antibodies Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Fragment-Based Antibodies
Table 3. Major Players of IgG-Based Antibodies
Table 4. Bispecific Monoclonal Antibodies Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Bispecific Monoclonal Antibodies Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Bispecific Monoclonal Antibodies Market Size Market Share by Type (2017-2022)
Table 7. Bispecific Monoclonal Antibodies Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Bispecific Monoclonal Antibodies Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Bispecific Monoclonal Antibodies Market Size Market Share by Application (2017-2022)
Table 10. Global Bispecific Monoclonal Antibodies Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Bispecific Monoclonal Antibodies Revenue Market Share by Player (2020-2022)
Table 12. Bispecific Monoclonal Antibodies Key Players Head office and Products Offered
Table 13. Bispecific Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Bispecific Monoclonal Antibodies Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Bispecific Monoclonal Antibodies Market Size Market Share by Regions (2017-2022)
Table 18. Americas Bispecific Monoclonal Antibodies Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Bispecific Monoclonal Antibodies Market Size Market Share by Country (2017-2022)
Table 20. Americas Bispecific Monoclonal Antibodies Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Bispecific Monoclonal Antibodies Market Size Market Share by Type (2017-2022)
Table 22. Americas Bispecific Monoclonal Antibodies Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Bispecific Monoclonal Antibodies Market Size Market Share by Application (2017-2022)
Table 24. APAC Bispecific Monoclonal Antibodies Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Bispecific Monoclonal Antibodies Market Size Market Share by Region (2017-2022)
Table 26. APAC Bispecific Monoclonal Antibodies Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Bispecific Monoclonal Antibodies Market Size Market Share by Type (2017-2022)
Table 28. APAC Bispecific Monoclonal Antibodies Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Bispecific Monoclonal Antibodies Market Size Market Share by Application (2017-2022)
Table 30. Europe Bispecific Monoclonal Antibodies Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Bispecific Monoclonal Antibodies Market Size Market Share by Country (2017-2022)
Table 32. Europe Bispecific Monoclonal Antibodies Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Bispecific Monoclonal Antibodies Market Size Market Share by Type (2017-2022)
Table 34. Europe Bispecific Monoclonal Antibodies Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Bispecific Monoclonal Antibodies Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Bispecific Monoclonal Antibodies Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Bispecific Monoclonal Antibodies Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Bispecific Monoclonal Antibodies Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Bispecific Monoclonal Antibodies Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Bispecific Monoclonal Antibodies
Table 43. Key Market Challenges & Risks of Bispecific Monoclonal Antibodies
Table 44. Key Industry Trends of Bispecific Monoclonal Antibodies
Table 45. Global Bispecific Monoclonal Antibodies Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Bispecific Monoclonal Antibodies Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Bispecific Monoclonal Antibodies Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Bispecific Monoclonal Antibodies Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Bispecific Monoclonal Antibodies Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Bispecific Monoclonal Antibodies Market Size Market Share Forecast by Application (2023-2028)
Table 51. Roche (Chugai) Details, Company Type, Bispecific Monoclonal Antibodies Area Served and Its Competitors
Table 52. Roche (Chugai) Bispecific Monoclonal Antibodies Product Offered
Table 53. Roche (Chugai) Bispecific Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Roche (Chugai) Main Business
Table 55. Roche (Chugai) Latest Developments
Table 56. Amgen Details, Company Type, Bispecific Monoclonal Antibodies Area Served and Its Competitors
Table 57. Amgen Bispecific Monoclonal Antibodies Product Offered
Table 58. Amgen Main Business
Table 59. Amgen Bispecific Monoclonal Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Amgen Latest Developments
List of Figures
Figure 1. Bispecific Monoclonal Antibodies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bispecific Monoclonal Antibodies Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Bispecific Monoclonal Antibodies Market Size Market Share by Type in 2021
Figure 7. Bispecific Monoclonal Antibodies in Cancer
Figure 8. Global Bispecific Monoclonal Antibodies Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Bispecific Monoclonal Antibodies in Haemophilia
Figure 10. Global Bispecific Monoclonal Antibodies Market: Haemophilia (2017-2022) & ($ Millions)
Figure 11. Bispecific Monoclonal Antibodies in Other Non-Cancer Diseases
Figure 12. Global Bispecific Monoclonal Antibodies Market: Other Non-Cancer Diseases (2017-2022) & ($ Millions)
Figure 13. Global Bispecific Monoclonal Antibodies Market Size Market Share by Application in 2021
Figure 14. Global Bispecific Monoclonal Antibodies Revenue Market Share by Player in 2021
Figure 15. Global Bispecific Monoclonal Antibodies Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Bispecific Monoclonal Antibodies Market Size 2017-2022 ($ Millions)
Figure 17. APAC Bispecific Monoclonal Antibodies Market Size 2017-2022 ($ Millions)
Figure 18. Europe Bispecific Monoclonal Antibodies Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Bispecific Monoclonal Antibodies Market Size 2017-2022 ($ Millions)
Figure 20. Americas Bispecific Monoclonal Antibodies Value Market Share by Country in 2021
Figure 21. Americas Bispecific Monoclonal Antibodies Consumption Market Share by Type in 2021
Figure 22. Americas Bispecific Monoclonal Antibodies Market Size Market Share by Application in 2021
Figure 23. United States Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Bispecific Monoclonal Antibodies Market Size Market Share by Region in 2021
Figure 28. APAC Bispecific Monoclonal Antibodies Market Size Market Share by Application in 2021
Figure 29. China Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Bispecific Monoclonal Antibodies Market Size Market Share by Country in 2021
Figure 36. Europe Bispecific Monoclonal Antibodies Market Size Market Share by Type in 2021
Figure 37. Europe Bispecific Monoclonal Antibodies Market Size Market Share by Application in 2021
Figure 38. Germany Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Bispecific Monoclonal Antibodies Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Bispecific Monoclonal Antibodies Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Bispecific Monoclonal Antibodies Market Size Market Share by Application in 2021
Figure 46. Egypt Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Bispecific Monoclonal Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 52. APAC Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 53. Europe Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 55. United States Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 56. Canada Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 59. China Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 60. Japan Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 61. Korea Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 63. India Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 64. Australia Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 65. Germany Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 66. France Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 67. UK Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 68. Italy Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 69. Russia Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 70. Spain Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 73. Israel Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Bispecific Monoclonal Antibodies Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets